United Therapeutics Corporation (UTHR)

United Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,788	15,752	10,333	12,674	9,731	6,746
Market Cap Growth	52.44%	52.44%	-18.47%	30.24%	44.26%	74.53%
Enterprise Value	8,384	11,546	6,197	9,415	7,022	4,738
Last Close Price	284.73	352.84	219.89	278.09	216.08	151.79
PE Ratio	11.56	13.18	10.49	17.43	20.45	13.10
Forward PE	10.48	12.17	9.93	13.57	13.45	11.39
PS Ratio	4.47	5.48	4.44	6.55	5.77	4.55
PB Ratio	1.98	2.44	1.73	2.64	2.46	1.99
P/TBV Ratio	2.02	2.49	1.76	2.67	2.49	2.08
P/FCF Ratio	11.83	14.58	13.82	19.10	20.38	9.69
P/OCF Ratio	9.64	11.87	10.57	15.79	16.27	8.93
PEG Ratio	-	1.02	13.47	1.03	0.74	1.27
EV/Sales Ratio	2.91	4.01	2.66	4.86	4.17	3.19
EV/EBITDA Ratio	5.52	7.60	5.00	9.05	9.53	7.33
EV/EBIT Ratio	5.80	7.98	5.23	9.52	10.22	7.94
EV/FCF Ratio	7.76	10.69	8.29	14.19	14.71	6.80
Debt / Equity Ratio	0.05	0.05	0.12	0.17	0.20	0.24
Debt / EBITDA Ratio	0.22	0.22	0.56	0.77	1.09	1.24
Debt / FCF Ratio	0.31	0.31	0.94	1.21	1.68	1.15
Asset Turnover	0.40	0.40	0.35	0.35	0.35	0.35
Inventory Turnover	2.30	2.30	2.41	1.55	1.36	1.20
Quick Ratio	4.81	4.81	4.10	9.12	6.97	6.16
Current Ratio	5.25	5.25	4.41	9.85	7.61	6.70
Return on Equity (ROE)	19.23%	19.23%	18.27%	16.61%	12.94%	16.67%
Return on Assets (ROA)	12.44%	12.44%	11.22%	11.03%	8.78%	8.74%
Return on Capital (ROIC)	13.42%	13.42%	12.07%	11.94%	9.59%	9.53%
Return on Capital Employed (ROCE)	21.80%	21.80%	18.60%	17.30%	14.10%	13.90%
Earnings Yield	934.56%	7.59%	9.53%	5.74%	4.89%	7.63%
FCF Yield	845.02%	6.86%	7.23%	5.24%	4.91%	10.32%
Buyback Yield / Dilution	241.40%	2.41%	-2.47%	-2.54%	-6.05%	-1.83%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q